Healthcare experts have said that Weight-loss surgery is more effective in treating form 4 diabetes in overweight. Dr. Francesco Rubino of Kings College London in the UK and Ireland and colleagues said half of those individuals who had weight-loss surgery were diabetes-free fir several years.
“The five-year point is a vital point in many sicknesses. The indisputable fact that some people at last 5 years are similar to disease-free is naturally an amazing getting," he said.
The researchers designated 20 affected individuals with variety more than 2 diabetes with different treatments including medication, a weight-loss surgery known as a gastric circumvent and another weight-loss procedure known as a biliopancreatic hindrance in 2009.
They found that 85 per cent of the people recorded blood glucose level below levels. Researchers at King’s College London and the UniversitaCattolica in Rome, Italy are the first study is provide data on five-year outcomes to validate the theory. Medical experts believe that they should use weight loss procedures instead of medication to treat form 4 diabetes in overweight individuals.
The study was published in Lancet.
In a recently published blog post, "social media theorist" and Snapchat researcher Nathan Jurgenson has revealed that Snapchat is funding a new online magazine called 'Real Life.'
In announcing that Snapchat is bankrolling the new 'Real...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
During the course of Thursday proceedings in the ongoing legal scuffle between Google and Oracle...
Paying in cash is any day better than taking a loan from a loan shark. In good old days people used a wad of cash to pay everything starting from furniture to grocery, if they did not have enough, they would wait for something cheaper or for the...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
In an apparent attempt to enhance the visual experience for Google search users carrying out...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
In a recently published blog post, "social media...
With tech giant Google scheduled to launch the Play...
Monohm Inc.’s incredibly weird circular smartphone-cum-...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).